SLC6A4 and major depressive disorder: Selective serotonin reuptake inhibitor (SSRI) antidepressants are known to increase the amount of serotonin at the synapse by inhibiting serotonin transporter (SERT); therefore, SERT has been hypothesized as an important player in the pathophysiology of MDD.